Produktbild: Pharmacoepigenetics

Pharmacoepigenetics

Fr. 313.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.05.2025

Herausgeber

Ramón Cacabelos

Verlag

Elsevier

Seitenzahl

1150

Maße (L/B)

27.6/21.6 cm

Gewicht

450 g

Auflage

2. Auflage

Sprache

Englisch

ISBN

978-0-443-18722-3

Beschreibung

Portrait

Dr. Ramón Cacabelos is Professor and Chairman of Genomic Medicine and President of the EuroEspes Biomedical Research Center, Corunna, Spain. He received his M.D. from Oviedo University, Oviedo, Spain; Ph.D. from Santiago University, Santiago de Compostela, Spain; and D.M.Sci. (Psychiatry) from Osaka University Medical School, Osaka, Japan. After a decade at the Department of Psychiatry in Osaka, he returned to Spain and focused his research activity on the genomics, epigenomics and pharmacogenomics of brain disorders, with special emphasis on neurodegenerative disorders (Alzheimer’s disease, Parkinson’s disease). He has published over 700 papers and 30 books and is Editor-in-Chief of the first World Guide for Drug Use and Pharmacogenomics and President of the World Association of Genomic Medicine.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.05.2025

Herausgeber

Ramón Cacabelos

Verlag

Elsevier

Seitenzahl

1150

Maße (L/B)

27.6/21.6 cm

Gewicht

450 g

Auflage

2. Auflage

Sprache

Englisch

ISBN

978-0-443-18722-3

Kundinnen und Kunden meinen

0 Bewertungen

Informationen zu Bewertungen

Zur Abgabe einer Bewertung ist eine Anmeldung im Konto notwendig. Die Authentizität der Bewertungen wird von uns nicht überprüft. Wir behalten uns vor, Bewertungstexte, die unseren Richtlinien widersprechen, entsprechend zu kürzen oder zu löschen.

Die Bewertungen sind nach Format, Anzahl Sterne und Datum sortiert.

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kund*innen durch Ihre Meinung

Kundinnen und Kunden meinen

0 Bewertungen filtern

Die Leseprobe wird geladen.
  • Produktbild: Pharmacoepigenetics
  • I. General Principles
    1.The Epigenetic Machinery in the Life Cycle
    2. Pharmacoepigenetics: Basic Principles for Personalized Medicine
    3. Pharmacoepigenetic Processors
    4. Epigenetic regulation of genes involved in drug metabolism
    5. MicroRNA-Dependent Gene Regulation of the Human Cytochromes P450
    6. Epigenetic regulation of transporter genes
    7. Pathoepigenetics: The Role of Epigenetic Biomarkers in Disease Pathogenesis

    II. Drug Development and Drug-related events
    8. Epigenetic Drugs
    9. Pharmacoepigenetics of Novel Nucleoside DNA Methyltransferase Inhibitors
    10. Pharmacoepigenetics: Novel Mechanistic Insights in Drug Discovery and Development Targeting Chromatin-Modifying Enzymes
    11. Pharmacoepigenetics of EZH2 Inhibitors
    12. Regulators of Histone Acetylation: Bromodomain Inhibitors
    13. Bromodomain Inhibition and Its Application to Human Disease
    14. Pharmacoepigenetics of Brassica-Derived Compounds
    15. Pharmacological Nicotinamide: Mechanisms Centered Around SIRT1 Activity
    16. Epigenetic-related Drug Resistance
    17. Toxicoepigenetics

    III. Pharmacoepigenetics of Cancer
    18. Epigenetics of Aging and Cancer: A Comprehensive Look
    19. Epigenetic Drug Discovery for Cancer
    20. Pharmacoepigenetics of Histone Deacetylase Inhibitors in Cancer
    21. Pharmacoepigenetics of LSD1 Inhibitors in Cancer
    22. Epigenetic effects of AntiGan in Cancer
    23. Pharmacoepigenetic Considerations for the Treatment of Breast Cancer
    24. Pharmacoepigenetics of Acute Myeloid Leukemia
    25. Therapeutic Potential of Pharmacoepigenetics in Cholangiocarcinoma
    26. Pharmacoepigenetics of Gastrointestinal disorders and Cancer
    27. Pharmacoepigenetics of Chinese Herbal Components in Cancer

    IV. Pharmacoepigenetics of Cardiovascular disease and Related disorders
    28. Epigenetics and Pharmacoepigenetics of myocardial infarction
    29. Epigenetics and Pharmacoepigenetics of Arteriosclerosis
    30. Epigenetics and Pharmacoepigenetics of Hypertension
    31. Pharmacoepigenetics of Ancoagulants
    32. Epigenetics in Doxorubicin Cardiotoxicity
    33. Epigenetic effects of CardioSar in cardiovascular disorders

    V. Pharmacoepigenetics of Central Nervous System disorders
    34. Epigenetics and Pharmacoepigenetics of Neurodevelopmental and Neuropsychiatric Disorders
    35. Pharmacoepigenetics and Toxicoepigenetics in Neurodevelopmental Disorders
    36. Pharmacoepigenetics of Autism Spectrum Disorder
    37. Pharmacoepigenetics of Antipsychotic Drugs
    38. Pharmacoepigenetics of Bipolar Disorder
    39. Pharmacoepigenetics of Major Depression
    40. Epigenetics and Pharmacoepigenetics of Vestibulocochlear disorders
    41. Epigenetics and Pharmacoepigenetics of Visual disorders
    42. Epigenetics and Pharmacoepigenetics of Age-Related Neurodegenerative Disorders
    43. Epigenetic effects of Nosustrophine in Alzheimer's disease
    44. Epigenetic effects of Atremorine in Parkinson's disease
    45. Pharmacoepigenetics and Pharmacoepigenomics of Valproate in Neurodegenerative Disease
    46. Pharmacoepigenetics of Memantine in Dementia

    VI. Pharmacoepigenetics of Metabolic and Endocrine disorders
    47. Pharmacoepigenetics in Type 2 Diabetes Mellitus
    48. Epigenetics and Pharmacoepigenetics of hypercholesterolemia and lipid metabolism disorders
    49. Pharmacoepigenetics of Statins
    50. Epigenetics and Pharmacoepigenetics of Thyroid disorders

    VII. Pharmacoepigenetics of Immunological and Inflammatory disorders
    51. Pharmacoepigenetics of Immunological Disorders
    52. Pharmacoepigenetics of Rheumatic Disorders
    53. Epigenetics and Pharmacoepigenetics of Skin disorders
    54. Pharmacoepigenetics of Systemic Lupus Erythematosus

    VIII. Nutritional Epigenetics
    55. Nutriepigenetics
    56. Epinutraceuticals: Novel biomolecules with epigenetic effects

    IX. Epigenetics and Pharmacoepigenetics of infectious disorders
    57. Pharmacoepigenetic of bacterial infections
    58. Pharmacoepigenetics of viral infections
    59. Pharmacoepigenetics of COVID-19

    X. Mendelian epigenetic disorders
    60. Pharmacoepigenetics of Mendelian disorders associated with the epigenetic machinery